Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

ClinicalTrials.gov ID: NCT02237950

Public ClinicalTrials.gov record NCT02237950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 9:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A double-blind, phase 3 study to determine the efficacy of SPL7013 Gel when administered on alternate days for 16 weeks, compared to placebo gel in preventing the recurrence of BV in women with a history of recurrent BV.

Study identification

NCT ID
NCT02237950
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Starpharma Pty Ltd
Industry
Enrollment
586 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 13, 2014 (Actual)
Primary completion
Dec 9, 2016 (Actual)
Completion
Feb 22, 2017 (Actual)
Last update posted
Jul 22, 2019

2014 – 2017

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
35
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233 —
Montgomery Women's Health Associates Montgomery Alabama 36117 —
Lynn Institute of the Ozarks Little Rock Arkansas 72205 —
Precision Research Institute San Diego California 92114 —
Women's Health Care San Diego California 92123 —
Lynn Institute of the Rockies Colorado Springs Colorado 80907 —
Downtown Women's Health Care Denver Colorado 80209 —
The Community Research South Florida Hialeah Florida 33016 —
Florida Medical Center and Research Inc. Miami Florida 33142 —
Research Institute of South Florida Miami Florida 33173 —
Community Medical Research Miami Beach Florida 33141 —
Comprehensive Clinical Trials West Palm Beach Florida 33409 —
Atlanta Medical Research Institute Alpharetta Georgia 30041 —
Urban Family Practice Associates Marietta Georgia 30067 —
Heartland Research Associates, LLC Newton Kansas 67114 —
Women's Healthcare Specialists Paw Paw Michigan 49079 —
Women's Clinic of Lincoln, PC Lincoln Nebraska 68510 —
Alegent Creighton Health Omaha Nebraska 68154 —
Affiliated Clinical Research Las Vegas Nevada 89105 —
Lawrence OB-GYN Associates Lawrenceville New Jersey 08648 —
PMG Research of Cary, LLC Cary North Carolina 27518 —
PMG Research of Salisbury Salisbury North Carolina 28144 —
Radiant Research Akron Ohio 44311 —
Radiant Research Columbus Ohio 43212 —
Lynn Institute of Norman Norman Oklahoma 73069 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Clinical Research of Philadelphia Philadelphia Pennsylvania 19114 —
Clinical Research Advantage Anderson South Carolina 29621 —
Medical University of South Carolina Charleston South Carolina 49425 —
Chattanooga Medical Research Chattanooga Tennessee 37404 —
Volunteer Research Group Knoxville Tennessee 37920 —
Women's Physician Group Memphis Tennessee 38104 —
Practice Research Organization Dallas Texas 75230 —
Radiant Research San Antonio Texas 78229 —
Jordan River Family Medicine South Jordan Utah 84088 —
Clinical Trials of Virginia Richmond Virginia 23225 —
Women's Clinical Research Center Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02237950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2019 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02237950 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →